Leukemia treatment has seen significant advancements with the introduction of targeted therapies like Venetoclax. The reliable synthesis of such drugs hinges on the availability of high-quality chemical components. NINGBO INNO PHARMCHEM CO.,LTD. is a dedicated provider of essential pharmaceutical intermediates, including the critical 2-(4-Chlorophenyl)-4,4-Dimethylcyclohex-1-Enecarbaldehyde (CAS No. 1228837-05-5).

This intermediate, with its specific chemical formula C15H17ClO, is fundamental in the production of Venetoclax, a drug that has transformed treatment protocols for patients with certain types of leukemia. The efficacy and safety of Venetoclax are directly linked to the purity and consistency of its precursor molecules. NINGBO INNO PHARMCHEM CO.,LTD. upholds the highest quality standards, evidenced by our GMP, ISO 9001, and FDA certifications, ensuring that our intermediate supports the development of effective and safe cancer therapies.

Our commitment at NINGBO INNO PHARMCHEM CO.,LTD. is to facilitate breakthroughs in medical treatment by supplying essential pharmaceutical intermediates. We understand the critical role these compounds play in the R&D process and manufacturing of APIs. By ensuring the availability and quality of CAS No. 1228837-05-5, we contribute to the ongoing efforts to improve patient outcomes and provide more targeted treatment options for leukemia patients. We aim to be a reliable source for specialized intermediates, supporting the pharmaceutical industry's mission to bring life-saving drugs to market efficiently and affordably.